COMP <GO>
NTRA vs ELV // EV/EBITDA & P/E VALUATION
Natera Inc. (NASDAQ) VS. Elevance Health Inc. (NYSE) • 15-METRIC TALLY: NTRA 4
— ELV 7
■ METRIC PARITY
LAST: $414.30 (-4.98%) • MKT CAP: $62.85B
valuation
—
LAST: $420.07 (-0.46%) • MKT CAP: $91.18B
valuation
13.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTRA VS. ELV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NTRA | ELV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 89.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.90% | 8.70% | -13.60 | ELV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 13.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.17% | 3.48% | -3.31 | ELV | /fcf-yield <GO> |
| Operating Margin | -13.40% | 3.60% | -17.00 | ELV | /operating-margins <GO> |
| Net Profit Margin | -9.00% | 2.80% | -11.80 | ELV | /net-margins <GO> |
| Revenue Growth (YoY) | 35.90% | 12.50% | +23.40 | NTRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.68% | -1.68 | ELV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 3.17 | +22.83 | NTRA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.0 | 52.0 | +12.00 | NTRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 1.07 | +0.02 | NTRA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 13.5x | +4.50 | ELV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $62.85B | $91.18B | -$28.33B | ELV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NTRA REV | ELV REV | NTRA GROSS % | ELV GROSS % | NTRA FCF | ELV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.31B | $199.13B | — | 89.4% | $109.1M | $3.17B |
| FY 2024 | $1.70B | $177.01B | — | 88.8% | $69.2M | $4.55B |
| FY 2023 | $1.08B | $171.34B | — | — | -$295.7M | $350.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTRA // BETA 1.09
ELV // BETA 1.07